Chronic kidney diseases Trials in Barcelona, Spain
Conditions / Chronic kidney diseases / Barcelona, Spain
Clinical trials for Chronic kidney diseases investigate a range of treatment strategies and patient populations.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04515849 | A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus | COMPLETED | PHASE2 |
| NCT05356403 | CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus | TERMINATED | PHASE3 |
| NCT05142501 | Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy | TERMINATED | — |
| NCT03749447 | An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) | TERMINATED | PHASE3 |
| NCT03119662 | A Study to Explore the Renal Safety of Visipaque Injection 320 mgI/mL in Patients With Chronic Kidney Disease | TERMINATED | PHASE4 |
| NCT05424809 | Feasibility and Preliminary Effectiveness of a Shared Decision-making Process | UNKNOWN | NA |
| NCT04968184 | Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD) | TERMINATED | PHASE3 |
| NCT03315143 | Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk | TERMINATED | PHASE3 |
| NCT06593392 | Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | RECRUITING | — |
| NCT06593392 | Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | RECRUITING | — |